Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FV-100 vs Valacyclovir for Acute Herpes Zoster and PHN Prevention
NCT02412917Phase 3Terminated
- Sponsor
- Hepion Pharmaceuticals
- Start
- Jun 2015
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of valnivudine in herpes zoster (HZ), postherpetic neuralgia (PHN), sponsored by Hepion Pharmaceuticals. Started Jun 2015; status: terminated.
02
Drugs
valnivudine
03
Conditions
herpes zoster (HZ)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT02412917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412917.